Rocket Lab Eyes Nasdaq-100 Debut as Synspective Launch Nears — Analyst Lifts Target to $135
Veröffentlicht: 15.06.2026 um 16:15 Uhr, Redaktion boerse-global.de
Rocket Lab is entering a pivotal stretch that could determine its near-term trajectory. On Tuesday, the company is set to launch its tenth satellite for Japanese Earth-observation firm Synspective aboard an Electron rocket — a mission that underscores the deepening relationship with a repeat customer. The flight, scheduled for June 17, marks the tenth dedicated mission for Synspective and comes as Rocket Lab’s launch sales in the first quarter of 2026 exceeded the total number of missions sold in all of 2025.
The operational momentum is colliding with a structural shift in the shareholder base. Rocket Lab will be added to the Nasdaq-100 index on June 22, forcing passive funds tracking the benchmark — which collectively manage roughly $800 billion — to buy the stock. That automatic demand arrives just days after the company endured a sharp sell-off triggered by the $75 billion initial public offering of SpaceX. Shares tumbled to €88.70 last Friday as institutional money rotated into Elon Musk’s newly public vehicle, punishing Rocket Lab as the closest proxy name in the sector.
By Monday, the stock had snapped back, rising 6.54% to €94.50. The recovery was fueled in part by an upgrade from KeyBanc Capital Markets, where analyst Michael Leshock raised his rating from Sector Weight to Overweight on June 14 and set a price target of $135 — implying roughly 43% upside from current levels. Leshock cited the company’s strong positioning across both commercial and military space markets.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The upgrade comes despite lingering questions about profitability. Rocket Lab generated total revenue of $344.1 million in the first quarter of 2026, with the space-systems segment — satellites, spacecraft components, and related services — now accounting for 66% of that figure. Launch services alone contributed a record $200.35 million, climbing 63.4% year over year. Adjusted EBITDA remained in negative territory at negative $11.8 million, a reflection of heavy spending on the heavy-lift Neutron rocket. That vehicle remains the company’s primary growth bet: first flight is targeted for the fourth quarter of 2026, with subsequent missions aimed at government and commercial contracts.
Rocket Lab’s financial runway looks comfortable. The company holds roughly $1.5 billion in cash and has an additional $3 billion available through an at-the-market equity program. The contract backlog has more than doubled to $2.2 billion, including $816 million from the Space Development Agency and $90 million from the U.S. Space Force. Of that total, $792 million is expected to convert into revenue within the next 12 months.
Technically, the stock is in a neutral zone after pulling back from its all-time high of €133.80 set on May 27. The relative strength index stood at 43.2 in one reading and 47.3 in another — both below overbought territory and leaving room for further upside. The 50-day moving average at €87.42 is providing near-term support. With the Synspective launch, the Nasdaq-100 inclusion, and the Neutron debut all lined up by year-end, the calendar offers a series of catalysts that could reframe the company’s valuation story.
Ad
Rocket Lab Stock: New Analysis - 15 June
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.
